Clinical Trial Update: Empyema Treated With tPA & DNAse [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating empyema treatment with intrapleural tPA and DNase has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Empyema

Drugs mentioned

• Activase (alteplase)
• Pulmozyme (dornase alfa)

Snippet

Sponsor: Children's Mercy Hospital Kansas City | Conditions: Empyema | Phase 3 | Status: WITHDRAWN